Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network

BackgroundVEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is an adult-onset autoinflammatory condition resulting in severe, often treatment-refractory inflammation. Currently, there are no established treatment guidelines for VEXAS syndrome.ObjectivesTo assess the efficacy...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Antonio Vitale, Flavia Leone, Valeria Caggiano, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Guillermo Arturo Guaracha-Basañez, Jiram Torres-Ruiz, Perla Ayumi Kawakami-Campos, Pravin Hissaria, Alicia Callisto, Mark Beecher, Lorenzo Dagna, Alessandro Tomelleri, Corrado Campochiaro, Micol Frassi, Francesca Crisafulli, Franco Franceschini, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Olga Araújo, Paolo Sfriso, Sara Bindoli, Chiara Baggio, Jessica Sbalchiero, Jurgen Sota, Abdurrahman Tufan, Ibrahim Vasi, Matteo Piga, Alberto Cauli, Maria Antonietta D’Agostino, Amato De Paulis, Ilaria Mormile, Henrique A. Mayrink Giardini, Rafael Alves Cordeiro, Francesco Gavioli, Giuseppe Lopalco, Florenzo Iannone, Carlomaurizio Montecucco, Sara Monti, Guillermo Ruiz-Irastorza, Adriana Soto-Peleteiro, Paola Triggianese, Carmelo Gurnari, Ombretta Viapiana, Riccardo Bixio, Rosetta Vitetta, Edoardo Conticini, Francesco La Torre, Gaafar Ragab, Ezgi Deniz Batu, Andrés González-García, Mercedes Peña-Rodríguez, Monica Bocchia, Ewa Wiesik-Szewczyk, Karina Jahnz-Rózyk, Alejandra de-la-Torre, Alberto Balistreri, Bruno Frediani, Claudia Fabiani, Luca Cantarini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Subjects:	cDMARDs clinical outcomes autoinflammatory diseases diagnosis treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1539756/full

Similar Items

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry
by: Antonio Vitale, et al.
Published: (2025-02-01)

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
by: Jurgen Sota, et al.
Published: (2026-06-01)

Development and implementation of the International AIDA Network Castleman’s disease registry
by: Antonio Vitale, et al.
Published: (2025-09-01)

Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries
by: Antonio Vitale, et al.
Published: (2024-08-01)

Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries
by: Antonio Vitale, et al.
Published: (2024-09-01)

Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview
by: S. Grazzini, et al.
Published: (2024-09-01)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
by: Giacomo De Luca, et al.
Published: (2021-03-01)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
by: Edoardo Conticini, et al.
Published: (2020-01-01)

Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight
by: Francesca Falcinelli, et al.
Published: (2025-04-01)

Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry
by: Antonio Vitale, et al.
Published: (2024-09-01)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
by: Giulio Cavalli, et al.
Published: (2019-02-01)

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease
by: Alessandro Tomelleri, et al.
Published: (2018-06-01)

A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)
by: Corrado Campochiaro, et al.
Published: (2021-09-01)

Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study
by: Grazzini S, et al.
Published: (2023-12-01)

Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study
by: Terribili R, et al.
Published: (2024-10-01)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review
by: Miriana d’Alessandro, et al.
Published: (2022-02-01)

Long-Term Outcomes of Behçet’s Syndrome-Related Uveitis: A Monocentric Italian Experience
by: Jurgen Sota, et al.
Published: (2020-01-01)

KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach
by: Edoardo Conticini, et al.
Published: (2022-01-01)

Routine IgG4 staining in minor salivary gland biopsy in a cohort of Italian Caucasian patients suffering from xerostomia
by: Edoardo Conticini, et al.
Published: (2022-02-01)

Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai
by: P. Falsetti, et al.
Published: (2020-11-01)

Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
by: Antonio Vitale, et al.
Published: (2023-05-01)

DP096 | COMBINATION OF 5-AZACITIDINE AND RUXOLITINIB IN VEXAS SYNDROME: A RETROSPECTIVE STUDY
by: G.M. Bergonzi, et al.
Published: (2025-09-01)

Ultrasound evaluation of the scapholunate ligament and scapholunate joint space in patients with wrist complaints in a rheumatologic setting
by: Falsetti Paolo, et al.
Published: (2021-06-01)

Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease
by: Antonio Vitale, et al.
Published: (2023-12-01)

Editorial: Insights into the diagnosis, pathogenesis and management of Takayasu arteritis
by: Durga Prasanna Misra, et al.
Published: (2026-06-01)

Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis Registry
by: Jurgen Sota, et al.
Published: (2026-05-01)

Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study
by: Maria Maddalena Angioni, et al.
Published: (2023-10-01)

The Role of Major Salivary Gland Ultrasound in the Diagnostic Workup of Sicca Syndrome: A Large Single-Centre Study
by: Giulia Vallifuoco, et al.
Published: (2024-01-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
by: Alberto Floris, et al.
Published: (2018-01-01)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
by: Matteo Piga, et al.
Published: (2017-11-01)

Immunological Pathways in Sarcoidosis and Autoimmune Rheumatic Disorders—Similarities and Differences in an Italian Prospective Real-Life Preliminary Study
by: Miriana d’Alessandro, et al.
Published: (2023-05-01)

Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study
by: Alberto Floris, et al.
Published: (2022-11-01)

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort
by: Elisa Diral, et al.
Published: (2024-01-01)

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast
by: Chiara Rizzo, et al.
Published: (2025-01-01)

Effects of antiresorptive agents on body composition: a case-control retrospective study
by: Suhel Gabriele Al Khayyat, et al.
Published: (2023-01-01)

26 Optimizing steroid-sparing drugs in SLE
by: Guillermo Ruiz-Irastorza
Published: (2023-09-01)

01 Glucocorticoids for SLE: what are the current questions and issues?
by: Guillermo Ruiz-Irastorza
Published: (2022-04-01)

Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study
by: Suhel Gabriele Al Khayyat, et al.
Published: (2021-08-01)

P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE
by: Carmelo Gurnari, et al.
Published: (2023-08-01)

Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study
by: Giacomo De Luca, et al.
Published: (2024-01-01)